Poster: The Role of Stable Housing and Food Security in Treatment Success Among People on HAART

Download PDF

Background:

The HIV epidemic in Canada is increasingly affecting marginalised groups. While highly active antiretroviral therapy (HAART) is freely available to those eligible, socioeconomic barriers too frequently prevent marginalised individuals from accessing therapy.

There are known links between the physical and social attributes of neighbourhoods, perception of neighbourhood attributes, health status and health-related risk behaviours.

The objective of this study was to determine the impact of stable housing, food security — two critical neighbourhood issues in British Columbia  along with other sociodemographic and clinical variables, on perception of neighbourhood among people receiving HAART.

Authors: K Vasarhelyi, EK Brandson, AK Palmer, K Fernandes, W Zhang, E Druyts, JS Montaner, RS Hogg

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search